Jonathan Miller interviews Nolan Jackson, partner at Frost Brown Todd and regulatory counsel to the US Hemp Roundtable, about major legislative and regulatory changes being made at the state level during 2024. If you have questions about the episode or ideas for Hemp related topics, email us at hemplegallyspeaking@fbtlaw.com.

Hemp Industry questions covered in the episode:

1. What is the impact of new laws passed by state legislatures in CT, SD, FL, GA, IA and TN?
2. What is the impact of new regulatory and administrative actions taken in DC, KY, and MD?
3. What is the status of legislation pending in CA, IL, LA and OH?
4. How can an individual or company keep apprised of the detailed changes being made on a regular basis in the states?

Jonathan Miller interviews Bill Bookout, President of the National Animal Supplements Council, about an exciting new study on the impact of hemp and CBD on household pets. If you have questions about the episode or ideas for Hemp related topics, email us at hemplegallyspeaking@fbtlaw.com.

Hemp Industry questions covered in the episode:

1. What is the current marketplace for hemp supplements for pets?
2. How are pet owners finding value for administering hemp and CBD?
3. What were the results of the new study NASC commissioned on the use of hemp and CBD for pets?
4. How will this study shape future regulatory action from the FDA?
5. What advice do you give to pet owners on hemp and CBD pet products?

Jonathan Miller interviews Uttam Dhillon, the former Acting Administrator of the Drug Enforcement Administration and current partner at Frost Brown Todd, about federal law enforcement views of hemp and cannabis, and the potential rescheduling and descheduling of cannabis. If you have questions about the episode or ideas for Hemp related topics, email us at hemplegallyspeaking@fbtlaw.com.

Hemp Industry questions covered in the episode:

1. As the DEA head when hemp was legalized, why was the agency so concerned about hemp prior to legalization?
2. What are the prospects of rescheduling cannabis, and what would serve as the regulatory framework?
3. Why is law enforcement so generally opposed to cannabis legalization?
4. Why does the DEA care about hemp/cannabis when there are so much more dangerous drugs affecting the country like heroin or fentanyl?
5. What are the most common misperceptions about DEA agent and their motivations?